Mark K Oki's Net Worth
$242 Thousand
Who is Mark K Oki?
Mark K Oki does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Alexza Pharmaceuticals Inc., AYTU BIOPHARMA, INC, and VIVUS INC.
SEC CIK
Mark K Oki's CIK is 0001491847
Past Insider Trading and Trends
2011 was Mark K Oki's most active year for acquiring shares with 7 total transactions. Mark K Oki's most active month to acquire stocks was the month of January. 2011 was Mark K Oki's most active year for disposing of shares, totalling 6 transactions. Mark K Oki's most active month to dispose stocks was the month of January. 2013 saw Mark K Oki paying a total of $193,375.00 for 131,250 shares, this is the most they've acquired in one year. In 2012 Mark K Oki cashed out on 41,873 shares for a total of $52,140.26, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Alexza Pharmaceuticals Inc. No price found
Former SVP, CFO, Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +755.87% | 43.75K |
$4.42 | $193,375.00 | 49.54K |
Mar 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -72.53% | -10.00K |
$4.14 | -$41,364.00 | 3.79K |
Scheduled
|
Aug 27
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 26
| |||
Form 4
| -18.77% | -31.87K |
$0.34 | -$10,776.26 | 137.9K |
Scheduled
|
Jun 6
| ||
Form 4
| +143.33% | 100K |
—
|
—
| 169.77K |
May 10
| |||
Form 4
| +84.11% | 31.87K |
—
|
—
| 69.77K |
Mar 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AYTU BIOPHARMA, INC (AYTU) Snapshot price: $2.48
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 11
| |||
Form 4/A
| +90.00% | 90K |
$0.23 | $20,700.00 | 190K |
Nov 18
| |||
Form 4
| +90.00% | 90K |
$0.23 | $20,700.00 | 190K |
Nov 18
| |||
Form 4
|
∞
| 100K |
—
|
—
| 100K |
Jan 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VIVUS INC No price found
Chief Financial Officer & CAO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
| +6.14% | 700 |
$2.38 | $1,666.00 | 12.1K |
Nov 14
| |||
Form 4
| +6.54% | 700 |
$2.84 | $1,988.00 | 11.4K |
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
| +7.00% | 700 |
$2.71 | $1,897.00 | 10.7K |
Nov 14
| |||
Form 4
|
∞
| 10K |
$4.07 | $40,700.00 | 10K |
Nov 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||